Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation.


Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
06 01 2023
Historique:
pubmed: 1 12 2022
medline: 10 1 2023
entrez: 30 11 2022
Statut: ppublish

Résumé

The development of metastasis severely reduces the life expectancy of patients with colorectal cancer (CRC). Although loss of SMAD4 is a key event in CRC progression, the resulting changes in biological processes in advanced disease and metastasis are not fully understood. Here, we applied a multiomics approach to a CRC organoid model that faithfully reflects the metastasis-supporting effects of SMAD4 inactivation. We show that loss of SMAD4 results in decreased differentiation and activation of pro-migratory and cell proliferation processes, which is accompanied by the disruption of several key oncogenic pathways, including the TGFβ, WNT, and VEGF pathways. In addition, SMAD4 inactivation leads to increased secretion of proteins that are known to be involved in a variety of pro-metastatic processes. Finally, we show that one of the factors that is specifically secreted by

Identifiants

pubmed: 36450103
doi: 10.1021/acs.jproteome.2c00551
pmc: PMC9830641
doi:

Substances chimiques

Transforming Growth Factor beta 0
Smad4 Protein 0
SMAD4 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-151

Références

Proteomics. 2005 Jul;5(10):2587-601
pubmed: 15912508
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Front Oncol. 2020 Nov 30;10:600322
pubmed: 33425757
Nat Commun. 2018 Jan 2;9(1):20
pubmed: 29295995
Biochimie. 2019 Feb;157:64-71
pubmed: 30414835
Int J Oncol. 2007 Apr;30(4):883-8
pubmed: 17332927
Cancer Res. 2022 May 16;82(10):1953-1968
pubmed: 35570706
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Sci Transl Med. 2018 Oct 24;10(464):
pubmed: 30355799
Nat Med. 2018 Mar;24(3):262-270
pubmed: 29431745
Gastroenterology. 2011 Jan;140(1):297-309
pubmed: 20951698
PLoS One. 2015 May 11;10(5):e0123768
pubmed: 25962058
Cancer Res. 2004 Mar 1;64(5):1600-3
pubmed: 14996716
Science. 2005 Mar 11;307(5715):1603-9
pubmed: 15761148
Front Cell Dev Biol. 2020 Feb 20;8:95
pubmed: 32154250
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
J Proteome Res. 2009 Dec;8(12):5674-8
pubmed: 19848406
Cancers (Basel). 2019 May 29;11(6):
pubmed: 31146452
Cancer Sci. 2012 Jan;103(1):7-16
pubmed: 21951556
Cancer Res. 2019 Jun 15;79(12):3011-3027
pubmed: 31053634
Nat Biotechnol. 2012 Oct;30(10):984-90
pubmed: 23000932
Cancer Res. 2018 Sep 1;78(17):4878-4890
pubmed: 29986996
JAMA. 2021 Feb 16;325(7):669-685
pubmed: 33591350
Semin Cancer Biol. 2014 Apr;25:15-22
pubmed: 24412104
Cancer Med. 2022 May;11(9):1925-1936
pubmed: 35274815
Nature. 2021 Jun;594(7863):436-441
pubmed: 34079128
Mol Cell Biol. 2005 Sep;25(18):8108-25
pubmed: 16135802
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Nat Protoc. 2020 Jan;15(1):15-39
pubmed: 31853056
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28423402
Cancer Sci. 2016 May;107(5):619-28
pubmed: 26892864
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Cell Biochem. 2013 Nov;114(11):2577-87
pubmed: 23744648
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14028-33
pubmed: 19667198
Oncogene. 2008 Jul 24;27(32):4467-77
pubmed: 18408752
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
J Proteome Res. 2014 Sep 5;13(9):4164-74
pubmed: 25077673
Biol Chem. 2014 Sep;395(9):1105-17
pubmed: 25153391
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Curr Opin Immunol. 2018 Apr;51:55-61
pubmed: 29525346
BMC Gastroenterol. 2021 Jul 23;21(1):297
pubmed: 34301194
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
Gastroenterology. 2014 Jul;147(1):196-208.e13
pubmed: 24704720
Front Immunol. 2015 Feb 24;6:78
pubmed: 25759692
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
iScience. 2021 Nov 15;24(12):103444
pubmed: 34877501
Dig Dis. 2019;37(3):214-225
pubmed: 30517925
Nucleic Acids Res. 2022 Mar 23;:
pubmed: 35325185
Trends Cancer. 2017 Feb;3(2):113-125
pubmed: 28718442
Clin Cancer Res. 2011 Jul 1;17(13):4331-40
pubmed: 21622717
Wiley Interdiscip Rev Dev Biol. 2013 Jan-Feb;2(1):47-63
pubmed: 23799630
Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):485-497
pubmed: 30343282
Front Genet. 2021 Nov 24;12:757897
pubmed: 34899842
Oncogene. 2008 Jan 3;27(1):85-97
pubmed: 17599042
Biol Chem. 2008 Jun;389(6):757-64
pubmed: 18627290
Int J Cancer. 2021 Oct 1;149(7):1495-1511
pubmed: 34146401
Proteomics Clin Appl. 2017 May;11(5-6):
pubmed: 28019089
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Biochim Biophys Acta. 2016 Mar;1863(3):438-448
pubmed: 26278055
Nat Commun. 2019 Jan 10;10(1):130
pubmed: 30631061
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Biomolecules. 2022 Jul 19;12(7):
pubmed: 35883559
Cell. 2019 Feb 21;176(5):1098-1112.e18
pubmed: 30794774
Cell. 2018 Sep 6;174(6):1586-1598.e12
pubmed: 30100188
Frontline Gastroenterol. 2014 Jan;5(1):26-30
pubmed: 24416503
Oncogene. 2021 Nov;40(45):6369-6380
pubmed: 34588619
Cancer Cell. 2012 Nov 13;22(5):571-84
pubmed: 23153532
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1631-6
pubmed: 22307622
Gastroenterology. 1996 Feb;110(2):375-82
pubmed: 8566583
J Cell Mol Med. 2021 Mar;25(6):2786-2794
pubmed: 33586359
Mol Cell Endocrinol. 2017 Dec 25;459:84-89
pubmed: 28342853
Nat Protoc. 2018 Mar;13(3):530-550
pubmed: 29446774
Gastroenterology. 2012 Mar;142(3):562-571.e2
pubmed: 22115830
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Mol Oncol. 2010 Dec;4(6):496-510
pubmed: 20934395
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell Rep. 2017 Jan 3;18(1):263-274
pubmed: 28052255
Oncol Lett. 2017 Feb;13(2):587-592
pubmed: 28356933
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2357-E2364
pubmed: 28270604
Mol Biosyst. 2010 Nov;6(11):2332-8
pubmed: 20862427
J Biol Chem. 2014 Aug 29;289(35):24238-49
pubmed: 25006253
Br J Cancer. 2015 Jan 6;112(1):122-30
pubmed: 25393365
Lab Invest. 2009 May;89(5):531-48
pubmed: 19308044
Nature. 2017 May 11;545(7653):187-192
pubmed: 28355176
Nucleic Acids Res. 2015 Jul 1;43(W1):W589-98
pubmed: 25897122
Gastroenterology. 2010 Apr;138(4):1406-17
pubmed: 20026115
Cell Rep. 2018 Feb 6;22(6):1600-1614
pubmed: 29425513
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Nature. 2021 Jun;594(7863):430-435
pubmed: 34079124
Cell. 2015 Aug 13;162(4):780-94
pubmed: 26276632
Mol Cancer. 2017 Jul 6;16(1):116
pubmed: 28683746
Mol Cancer. 2016 Dec 3;15(1):77
pubmed: 27912767
Mol Cell Proteomics. 2013 Jun;12(6):1602-20
pubmed: 23443137
J Transl Med. 2013 Jun 10;11:142
pubmed: 23758705
Cancer Med. 2019 Sep;8(11):5352-5366
pubmed: 31353847
Arch Biochem Biophys. 2012 Aug 1;524(1):71-6
pubmed: 22230326
Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G135-45
pubmed: 16769811
Int J Mol Sci. 2019 Nov 20;20(23):
pubmed: 31756952
Gene. 1999 Oct 1;238(2):301-13
pubmed: 10570958
Oncogene. 2019 Feb;38(6):780-793
pubmed: 30181548
Sci Rep. 2018 Feb 16;8(1):3178
pubmed: 29453334

Auteurs

Jelmer J Dijkstra (JJ)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Hannah K Neikes (HK)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Somayeh Rezaeifard (S)

Department of Cell Biology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Xuhui Ma (X)

Department of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.

Emile E Voest (EE)

Department of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.

Daniele V F Tauriello (DVF)

Department of Cell Biology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Michiel Vermeulen (M)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH